IRMD logo
IRadimed Corporation(IRMD)
Last print unknown agoAbout this dataData status
$87.65▼-0.62 (-0.70%)Stale · unknown oldEarnings · Nov 2

IRMD R&D Expense Growth

5.06%Fiscal year

Period ending:

IRMD FY R&D Growth (YoY)%
IRMD FY R&D Growth (YoY)75.74%-34.27%
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

IRMD r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Iradimed Corp R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
5.0647%
-0.9468%
25.4853%
19.5816%
0.1321%
32.7916%
-5.5627%
-11.9271%
27.8334%
-23.624%
65.093%
5.8227%
54.3982%
0%

Compare r&d expense growth

All IRMD financial metrics · IRMD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.